FDA Inspection
Bristol-Myers Squibb Holdings Pharma Ltd. Liability CompanyBristol-Myers Squibb Holdings Pharma Ltd. Liability Company – FDA Inspection, Feb 13, 2026
Record Details
This FDA Inspection record concerns Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company, with an inspection on February 13, 2026, issued by the San Juan District Office, covering human drugs.
- Inspection Date
- February 13, 2026
- Product Type
- Human Drugs
View Company Profile
ID · d4edb78e-8539-4958-aa1f-3f9b7c722066
Inspection Facts
- Inspection number
- 1305236
- FDA center
- Human Drugs
Other FDA inspections of Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
13| Date | Classification | Office | Project area |
|---|---|---|---|
| June 6, 2024 | Not classified | San Juan District Office | |
| July 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 19, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.